GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » QUIA PHARMA AB (OSTO:QUIA) » Definitions » ROE % Adjusted to Book Value

QUIA PHARMA AB (OSTO:QUIA) ROE % Adjusted to Book Value : -150.91% (As of Dec. 2024)


View and export this data going back to 2005. Start your Free Trial

What is QUIA PHARMA AB ROE % Adjusted to Book Value?

QUIA PHARMA AB's ROE % for the quarter that ended in Dec. 2024 was -170.53%. QUIA PHARMA AB's PB Ratio for the quarter that ended in Dec. 2024 was 1.13. QUIA PHARMA AB's ROE % Adjusted to Book Value for the quarter that ended in Dec. 2024 was -150.91%.


QUIA PHARMA AB ROE % Adjusted to Book Value Historical Data

The historical data trend for QUIA PHARMA AB's ROE % Adjusted to Book Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

QUIA PHARMA AB ROE % Adjusted to Book Value Chart

QUIA PHARMA AB Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
ROE % Adjusted to Book Value
Get a 7-Day Free Trial Premium Member Only Premium Member Only - -21.26 -129.11 -584.66 -162.01

QUIA PHARMA AB Semi-Annual Data
Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24
ROE % Adjusted to Book Value Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -20.99 -166.94 -348.84 -20.10 -150.91

Competitive Comparison of QUIA PHARMA AB's ROE % Adjusted to Book Value

For the Biotechnology subindustry, QUIA PHARMA AB's ROE % Adjusted to Book Value, along with its competitors' market caps and ROE % Adjusted to Book Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


QUIA PHARMA AB's ROE % Adjusted to Book Value Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, QUIA PHARMA AB's ROE % Adjusted to Book Value distribution charts can be found below:

* The bar in red indicates where QUIA PHARMA AB's ROE % Adjusted to Book Value falls into.


;
;

QUIA PHARMA AB ROE % Adjusted to Book Value Calculation

QUIA PHARMA AB's ROE % Adjusted to Book Value for the fiscal year that ended in Dec. 2024 is calculated as

ROE % Adjusted to Book Value=ROE % / PB Ratio
=-183.07% / 1.13
=-162.01%

QUIA PHARMA AB's ROE % Adjusted to Book Value for the quarter that ended in Dec. 2024 is calculated as

ROE % Adjusted to Book Value=ROE % / PB Ratio
=-170.53% / 1.13
=-150.91%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


QUIA PHARMA AB ROE % Adjusted to Book Value Related Terms

Thank you for viewing the detailed overview of QUIA PHARMA AB's ROE % Adjusted to Book Value provided by GuruFocus.com. Please click on the following links to see related term pages.


QUIA PHARMA AB Business Description

Industry
Traded in Other Exchanges
Address
Virdings Alle 32 B, Uppsala, SWE, 754 50
QUIA PHARMA AB is a development company for pharmaceuticals based on a patented drug delivery platform, Uni-Qleaver. The company develops improved and patentable forms of drugs under development or already approved by pharmaceutical authorities. These refined and enhanced forms of medicine are based on the Company's exceptional and patented technology platform. In addition to this, the Company offers multinational sales of omega-3, astaxin and collagen through Amazon.

QUIA PHARMA AB Headlines

No Headlines